id	sid	tid	token	lemma	pos
cord-307471-zukjh1hr	1	1	key	key	JJ
cord-307471-zukjh1hr	1	2	:	:	:
cord-307471-zukjh1hr	1	3	cord-307471-zukjh1hr	cord-307471-zukjh1hr	CD
cord-307471-zukjh1hr	1	4	authors	author	NNS
cord-307471-zukjh1hr	1	5	:	:	:
cord-307471-zukjh1hr	1	6	Feng	Feng	NNP
cord-307471-zukjh1hr	1	7	,	,	,
cord-307471-zukjh1hr	1	8	Zhilan	Zhilan	NNP
cord-307471-zukjh1hr	1	9	;	;	:
cord-307471-zukjh1hr	1	10	Glasser	Glasser	NNP
cord-307471-zukjh1hr	1	11	,	,	,
cord-307471-zukjh1hr	1	12	John	John	NNP
cord-307471-zukjh1hr	1	13	W.	W.	NNP
cord-307471-zukjh1hr	1	14	;	;	:
cord-307471-zukjh1hr	1	15	Hill	Hill	NNP
cord-307471-zukjh1hr	1	16	,	,	,
cord-307471-zukjh1hr	1	17	Andrew	Andrew	NNP
cord-307471-zukjh1hr	1	18	N.	N.	NNP
cord-307471-zukjh1hr	1	19	title	title	NN
cord-307471-zukjh1hr	1	20	:	:	:
cord-307471-zukjh1hr	2	1	On	on	IN
cord-307471-zukjh1hr	2	2	the	the	DT
cord-307471-zukjh1hr	2	3	benefits	benefit	NNS
cord-307471-zukjh1hr	2	4	of	of	IN
cord-307471-zukjh1hr	2	5	flattening	flatten	VBG
cord-307471-zukjh1hr	2	6	the	the	DT
cord-307471-zukjh1hr	2	7	curve	curve	NN
cord-307471-zukjh1hr	2	8	:	:	:
cord-307471-zukjh1hr	2	9	A	a	DT
cord-307471-zukjh1hr	2	10	perspective	perspective	NN
cord-307471-zukjh1hr	2	11	(	(	-LRB-
cord-307471-zukjh1hr	2	12	)	)	-RRB-
cord-307471-zukjh1hr	2	13	date	date	NN
cord-307471-zukjh1hr	2	14	:	:	:
cord-307471-zukjh1hr	2	15	2020	2020	CD
cord-307471-zukjh1hr	2	16	-	-	HYPH
cord-307471-zukjh1hr	2	17	05	05	CD
cord-307471-zukjh1hr	2	18	-	-	HYPH
cord-307471-zukjh1hr	2	19	27	27	CD
cord-307471-zukjh1hr	2	20	journal	journal	NN
cord-307471-zukjh1hr	2	21	:	:	:
cord-307471-zukjh1hr	3	1	Math	Math	NNP
cord-307471-zukjh1hr	3	2	Biosci	Biosci	NNP
cord-307471-zukjh1hr	4	1	DOI	DOI	NNP
cord-307471-zukjh1hr	4	2	:	:	:
cord-307471-zukjh1hr	4	3	10.1016	10.1016	CD
cord-307471-zukjh1hr	4	4	/	/	SYM
cord-307471-zukjh1hr	4	5	j.mbs.2020.108389	j.mbs.2020.108389	JJ
cord-307471-zukjh1hr	4	6	sha	sha	NNP
cord-307471-zukjh1hr	4	7	:	:	:
cord-307471-zukjh1hr	5	1	7ffd042b919518a067b92b9678c1d71a12e548fd	7ffd042b919518a067b92b9678c1d71a12e548fd	NFP
cord-307471-zukjh1hr	5	2	doc_id	doc_id	CD
cord-307471-zukjh1hr	5	3	:	:	:
cord-307471-zukjh1hr	6	1	307471	307471	CD
cord-307471-zukjh1hr	6	2	cord_uid	cord_uid	NN
cord-307471-zukjh1hr	6	3	:	:	:
cord-307471-zukjh1hr	6	4	zukjh1hr	zukjh1hr	NNP
cord-307471-zukjh1hr	7	1	The	the	DT
cord-307471-zukjh1hr	7	2	many	many	JJ
cord-307471-zukjh1hr	7	3	variations	variation	NNS
cord-307471-zukjh1hr	7	4	on	on	IN
cord-307471-zukjh1hr	7	5	a	a	DT
cord-307471-zukjh1hr	7	6	graphic	graphic	NN
cord-307471-zukjh1hr	7	7	illustrating	illustrate	VBG
cord-307471-zukjh1hr	7	8	the	the	DT
cord-307471-zukjh1hr	7	9	impact	impact	NN
cord-307471-zukjh1hr	7	10	of	of	IN
cord-307471-zukjh1hr	7	11	non	non	JJ
cord-307471-zukjh1hr	7	12	-	-	JJ
cord-307471-zukjh1hr	7	13	pharmaceutical	pharmaceutical	JJ
cord-307471-zukjh1hr	7	14	measures	measure	NNS
cord-307471-zukjh1hr	7	15	to	to	TO
cord-307471-zukjh1hr	7	16	mitigate	mitigate	VB
cord-307471-zukjh1hr	7	17	pandemic	pandemic	NN
cord-307471-zukjh1hr	7	18	influenza	influenza	NN
cord-307471-zukjh1hr	7	19	that	that	WDT
cord-307471-zukjh1hr	7	20	have	have	VBP
cord-307471-zukjh1hr	7	21	appeared	appear	VBN
cord-307471-zukjh1hr	7	22	in	in	IN
cord-307471-zukjh1hr	7	23	recent	recent	JJ
cord-307471-zukjh1hr	7	24	news	news	NN
cord-307471-zukjh1hr	7	25	reports	report	NNS
cord-307471-zukjh1hr	7	26	about	about	IN
cord-307471-zukjh1hr	7	27	COVID-19	COVID-19	NNP
cord-307471-zukjh1hr	7	28	suggest	suggest	VBP
cord-307471-zukjh1hr	7	29	a	a	DT
cord-307471-zukjh1hr	7	30	need	need	NN
cord-307471-zukjh1hr	7	31	to	to	TO
cord-307471-zukjh1hr	7	32	better	better	RB
cord-307471-zukjh1hr	7	33	explain	explain	VB
cord-307471-zukjh1hr	7	34	the	the	DT
cord-307471-zukjh1hr	7	35	mechanism	mechanism	NN
cord-307471-zukjh1hr	7	36	by	by	IN
cord-307471-zukjh1hr	7	37	which	which	WDT
cord-307471-zukjh1hr	7	38	social	social	JJ
cord-307471-zukjh1hr	7	39	distancing	distancing	NN
cord-307471-zukjh1hr	7	40	reduces	reduce	VBZ
cord-307471-zukjh1hr	7	41	the	the	DT
cord-307471-zukjh1hr	7	42	spread	spread	NN
cord-307471-zukjh1hr	7	43	of	of	IN
cord-307471-zukjh1hr	7	44	infectious	infectious	JJ
cord-307471-zukjh1hr	7	45	diseases	disease	NNS
cord-307471-zukjh1hr	7	46	.	.	.
cord-307471-zukjh1hr	8	1	And	and	CC
cord-307471-zukjh1hr	8	2	some	some	DT
cord-307471-zukjh1hr	8	3	reports	report	NNS
cord-307471-zukjh1hr	8	4	understate	understate	VBP
cord-307471-zukjh1hr	8	5	one	one	CD
cord-307471-zukjh1hr	8	6	benefit	benefit	NN
cord-307471-zukjh1hr	8	7	of	of	IN
cord-307471-zukjh1hr	8	8	reducing	reduce	VBG
cord-307471-zukjh1hr	8	9	the	the	DT
cord-307471-zukjh1hr	8	10	frequency	frequency	NN
cord-307471-zukjh1hr	8	11	or	or	CC
cord-307471-zukjh1hr	8	12	proximity	proximity	NN
cord-307471-zukjh1hr	8	13	of	of	IN
cord-307471-zukjh1hr	8	14	interpersonal	interpersonal	JJ
cord-307471-zukjh1hr	8	15	encounters	encounter	NNS
cord-307471-zukjh1hr	8	16	,	,	,
cord-307471-zukjh1hr	8	17	a	a	DT
cord-307471-zukjh1hr	8	18	reduction	reduction	NN
cord-307471-zukjh1hr	8	19	in	in	IN
cord-307471-zukjh1hr	8	20	the	the	DT
cord-307471-zukjh1hr	8	21	total	total	JJ
cord-307471-zukjh1hr	8	22	number	number	NN
cord-307471-zukjh1hr	8	23	of	of	IN
cord-307471-zukjh1hr	8	24	infections	infection	NNS
cord-307471-zukjh1hr	8	25	.	.	.
cord-307471-zukjh1hr	9	1	In	in	IN
cord-307471-zukjh1hr	9	2	hopes	hope	NNS
cord-307471-zukjh1hr	9	3	that	that	IN
cord-307471-zukjh1hr	9	4	understanding	understanding	NN
cord-307471-zukjh1hr	9	5	will	will	MD
cord-307471-zukjh1hr	9	6	increase	increase	VB
cord-307471-zukjh1hr	9	7	compliance	compliance	NN
cord-307471-zukjh1hr	9	8	,	,	,
cord-307471-zukjh1hr	9	9	we	-PRON-	PRP
cord-307471-zukjh1hr	9	10	describe	describe	VBP
cord-307471-zukjh1hr	9	11	how	how	WRB
cord-307471-zukjh1hr	9	12	social	social	JJ
cord-307471-zukjh1hr	9	13	distancing	distance	VBG
cord-307471-zukjh1hr	9	14	a	a	DT
cord-307471-zukjh1hr	9	15	)	)	-RRB-
cord-307471-zukjh1hr	9	16	reduces	reduce	VBZ
cord-307471-zukjh1hr	9	17	the	the	DT
cord-307471-zukjh1hr	9	18	peak	peak	NN
cord-307471-zukjh1hr	9	19	incidence	incidence	NN
cord-307471-zukjh1hr	9	20	of	of	IN
cord-307471-zukjh1hr	9	21	infections	infection	NNS
cord-307471-zukjh1hr	9	22	,	,	,
cord-307471-zukjh1hr	9	23	b	b	LS
cord-307471-zukjh1hr	9	24	)	)	-RRB-
cord-307471-zukjh1hr	9	25	delays	delay	VBZ
cord-307471-zukjh1hr	9	26	the	the	DT
cord-307471-zukjh1hr	9	27	occurrence	occurrence	NN
cord-307471-zukjh1hr	9	28	of	of	IN
cord-307471-zukjh1hr	9	29	this	this	DT
cord-307471-zukjh1hr	9	30	peak	peak	NN
cord-307471-zukjh1hr	9	31	,	,	,
cord-307471-zukjh1hr	9	32	and	and	CC
cord-307471-zukjh1hr	9	33	c	c	LS
cord-307471-zukjh1hr	9	34	)	)	-RRB-
cord-307471-zukjh1hr	9	35	reduces	reduce	VBZ
cord-307471-zukjh1hr	9	36	the	the	DT
cord-307471-zukjh1hr	9	37	total	total	JJ
cord-307471-zukjh1hr	9	38	number	number	NN
cord-307471-zukjh1hr	9	39	of	of	IN
cord-307471-zukjh1hr	9	40	infections	infection	NNS
cord-307471-zukjh1hr	9	41	during	during	IN
cord-307471-zukjh1hr	9	42	epidemics	epidemic	NNS
cord-307471-zukjh1hr	9	43	.	.	.
cord-307471-zukjh1hr	10	1	In	in	IN
cord-307471-zukjh1hr	10	2	view	view	NN
cord-307471-zukjh1hr	10	3	of	of	IN
cord-307471-zukjh1hr	10	4	the	the	DT
cord-307471-zukjh1hr	10	5	extraordinary	extraordinary	JJ
cord-307471-zukjh1hr	10	6	efforts	effort	NNS
cord-307471-zukjh1hr	10	7	underway	underway	JJ
cord-307471-zukjh1hr	10	8	to	to	TO
cord-307471-zukjh1hr	10	9	identify	identify	VB
cord-307471-zukjh1hr	10	10	existing	exist	VBG
cord-307471-zukjh1hr	10	11	medications	medication	NNS
cord-307471-zukjh1hr	10	12	that	that	WDT
cord-307471-zukjh1hr	10	13	are	be	VBP
cord-307471-zukjh1hr	10	14	active	active	JJ
cord-307471-zukjh1hr	10	15	against	against	IN
cord-307471-zukjh1hr	10	16	SARS	SARS	NNP
cord-307471-zukjh1hr	10	17	-	-	HYPH
cord-307471-zukjh1hr	10	18	CoV-2	CoV-2	NNP
cord-307471-zukjh1hr	10	19	and	and	CC
cord-307471-zukjh1hr	10	20	to	to	TO
cord-307471-zukjh1hr	10	21	develop	develop	VB
cord-307471-zukjh1hr	10	22	new	new	JJ
cord-307471-zukjh1hr	10	23	antiviral	antiviral	JJ
cord-307471-zukjh1hr	10	24	drugs	drug	NNS
cord-307471-zukjh1hr	10	25	,	,	,
cord-307471-zukjh1hr	10	26	vaccines	vaccine	NNS
cord-307471-zukjh1hr	10	27	and	and	CC
cord-307471-zukjh1hr	10	28	antibody	antibody	NN
cord-307471-zukjh1hr	10	29	therapies	therapy	NNS
cord-307471-zukjh1hr	10	30	,	,	,
cord-307471-zukjh1hr	10	31	any	any	DT
cord-307471-zukjh1hr	10	32	of	of	IN
cord-307471-zukjh1hr	10	33	which	which	WDT
cord-307471-zukjh1hr	10	34	may	may	MD
cord-307471-zukjh1hr	10	35	have	have	VB
cord-307471-zukjh1hr	10	36	community	community	NN
cord-307471-zukjh1hr	10	37	-	-	HYPH
cord-307471-zukjh1hr	10	38	level	level	NN
cord-307471-zukjh1hr	10	39	effects	effect	NNS
cord-307471-zukjh1hr	10	40	,	,	,
cord-307471-zukjh1hr	10	41	we	-PRON-	PRP
cord-307471-zukjh1hr	10	42	also	also	RB
cord-307471-zukjh1hr	10	43	describe	describe	VBP
cord-307471-zukjh1hr	10	44	how	how	WRB
cord-307471-zukjh1hr	10	45	pharmaceutical	pharmaceutical	JJ
cord-307471-zukjh1hr	10	46	interventions	intervention	NNS
cord-307471-zukjh1hr	10	47	affect	affect	VBP
cord-307471-zukjh1hr	10	48	transmission	transmission	NN
cord-307471-zukjh1hr	10	49	.	.	.
cord-307471-zukjh1hr	11	1			NFP
cord-307471-zukjh1hr	12	1	Social	social	JJ
cord-307471-zukjh1hr	12	2	distancing	distancing	NN
cord-307471-zukjh1hr	12	3	refers	refer	VBZ
cord-307471-zukjh1hr	12	4	to	to	IN
cord-307471-zukjh1hr	12	5	non	non	JJ
cord-307471-zukjh1hr	12	6	-	-	JJ
cord-307471-zukjh1hr	12	7	pharmaceutical	pharmaceutical	JJ
cord-307471-zukjh1hr	12	8	measures	measure	NNS
cord-307471-zukjh1hr	12	9	to	to	TO
cord-307471-zukjh1hr	12	10	reduce	reduce	VB
cord-307471-zukjh1hr	12	11	the	the	DT
cord-307471-zukjh1hr	12	12	frequency	frequency	NN
cord-307471-zukjh1hr	12	13	or	or	CC
cord-307471-zukjh1hr	12	14	proximity	proximity	NN
cord-307471-zukjh1hr	12	15	of	of	IN
cord-307471-zukjh1hr	12	16	interpersonal	interpersonal	JJ
cord-307471-zukjh1hr	12	17	encounters	encounter	NNS
cord-307471-zukjh1hr	12	18			.
cord-307471-zukjh1hr	13	1	The	the	DT
cord-307471-zukjh1hr	13	2	impact	impact	NN
cord-307471-zukjh1hr	13	3	of	of	IN
cord-307471-zukjh1hr	13	4	these	these	DT
cord-307471-zukjh1hr	13	5	measures	measure	NNS
cord-307471-zukjh1hr	13	6	on	on	IN
cord-307471-zukjh1hr	13	7	epidemic	epidemic	NN
cord-307471-zukjh1hr	13	8	curves	curve	NNS
cord-307471-zukjh1hr	13	9	is	be	VBZ
cord-307471-zukjh1hr	13	10	commonly	commonly	RB
cord-307471-zukjh1hr	13	11	misrepresented	misrepresent	VBN
cord-307471-zukjh1hr	13	12	,	,	,
cord-307471-zukjh1hr	13	13	suggesting	suggest	VBG
cord-307471-zukjh1hr	13	14	a	a	DT
cord-307471-zukjh1hr	13	15	lack	lack	NN
cord-307471-zukjh1hr	13	16	of	of	IN
cord-307471-zukjh1hr	13	17	understanding	understanding	NN
cord-307471-zukjh1hr	13	18	of	of	IN
cord-307471-zukjh1hr	13	19	the	the	DT
cord-307471-zukjh1hr	13	20	underlying	underlie	VBG
cord-307471-zukjh1hr	13	21	mechanisms	mechanism	NNS
cord-307471-zukjh1hr	13	22			CD
cord-307471-zukjh1hr	13	23	As	as	IN
cord-307471-zukjh1hr	13	24	this	this	DT
cord-307471-zukjh1hr	13	25	may	may	MD
cord-307471-zukjh1hr	13	26	affect	affect	VB
cord-307471-zukjh1hr	13	27	compliance	compliance	NN
cord-307471-zukjh1hr	13	28	with	with	IN
cord-307471-zukjh1hr	13	29	recommendations	recommendation	NNS
cord-307471-zukjh1hr	13	30	,	,	,
cord-307471-zukjh1hr	13	31	we	-PRON-	PRP
cord-307471-zukjh1hr	13	32	describe	describe	VBP
cord-307471-zukjh1hr	13	33	determinants	determinant	NNS
cord-307471-zukjh1hr	13	34	of	of	IN
cord-307471-zukjh1hr	13	35	the	the	DT
cord-307471-zukjh1hr	13	36	magnitude	magnitude	NN
cord-307471-zukjh1hr	13	37	and	and	CC
cord-307471-zukjh1hr	13	38	timing	timing	NN
cord-307471-zukjh1hr	13	39	of	of	IN
cord-307471-zukjh1hr	13	40	peak	peak	NN
cord-307471-zukjh1hr	13	41	incidence	incidence	NN
cord-307471-zukjh1hr	13	42	and	and	CC
cord-307471-zukjh1hr	13	43	the	the	DT
cord-307471-zukjh1hr	13	44	total	total	JJ
cord-307471-zukjh1hr	13	45	number	number	NN
cord-307471-zukjh1hr	13	46	of	of	IN
cord-307471-zukjh1hr	13	47	infections	infection	NNS
cord-307471-zukjh1hr	13	48			.
cord-307471-zukjh1hr	14	1	We	-PRON-	PRP
cord-307471-zukjh1hr	14	2	also	also	RB
cord-307471-zukjh1hr	14	3	describe	describe	VBP
cord-307471-zukjh1hr	14	4	possible	possible	JJ
cord-307471-zukjh1hr	14	5	population	population	NN
cord-307471-zukjh1hr	14	6	-	-	HYPH
cord-307471-zukjh1hr	14	7	level	level	NN
cord-307471-zukjh1hr	14	8	effects	effect	NNS
cord-307471-zukjh1hr	14	9	of	of	IN
cord-307471-zukjh1hr	14	10	pharmaceutical	pharmaceutical	JJ
cord-307471-zukjh1hr	14	11	interventions	intervention	NNS
cord-307471-zukjh1hr	15	1	The	the	DT
cord-307471-zukjh1hr	15	2	most	most	RBS
cord-307471-zukjh1hr	15	3	recent	recent	JJ
cord-307471-zukjh1hr	15	4	community	community	NN
cord-307471-zukjh1hr	15	5	mitigation	mitigation	NN
cord-307471-zukjh1hr	15	6	guidelines	guideline	NNS
cord-307471-zukjh1hr	15	7	for	for	IN
cord-307471-zukjh1hr	15	8	pandemic	pandemic	NN
cord-307471-zukjh1hr	15	9	influenza	influenza	NN
cord-307471-zukjh1hr	16	1	(	(	-LRB-
cord-307471-zukjh1hr	16	2	Qualls	Qualls	NNP
cord-307471-zukjh1hr	16	3	et	et	NNP
cord-307471-zukjh1hr	16	4	al	al	NNP
cord-307471-zukjh1hr	16	5	.	.	.
cord-307471-zukjh1hr	16	6	2017	2017	CD
cord-307471-zukjh1hr	16	7	)	)	-RRB-
cord-307471-zukjh1hr	16	8	include	include	VBP
cord-307471-zukjh1hr	16	9	a	a	DT
cord-307471-zukjh1hr	16	10	graphic	graphic	NN
cord-307471-zukjh1hr	16	11	illustrating	illustrate	VBG
cord-307471-zukjh1hr	16	12	the	the	DT
cord-307471-zukjh1hr	16	13	goals	goal	NNS
cord-307471-zukjh1hr	16	14	of	of	IN
cord-307471-zukjh1hr	16	15	non	non	JJ
cord-307471-zukjh1hr	16	16	-	-	JJ
cord-307471-zukjh1hr	16	17	pharmaceutical	pharmaceutical	JJ
cord-307471-zukjh1hr	16	18	interventions	intervention	NNS
cord-307471-zukjh1hr	16	19	,	,	,
cord-307471-zukjh1hr	16	20	slowing	slow	VBG
cord-307471-zukjh1hr	16	21	the	the	DT
cord-307471-zukjh1hr	16	22	rate	rate	NN
cord-307471-zukjh1hr	16	23	at	at	IN
cord-307471-zukjh1hr	16	24	which	which	WDT
cord-307471-zukjh1hr	16	25	new	new	JJ
cord-307471-zukjh1hr	16	26	infections	infection	NNS
cord-307471-zukjh1hr	16	27	occur	occur	VBP
cord-307471-zukjh1hr	16	28	(	(	-LRB-
cord-307471-zukjh1hr	16	29	incidence	incidence	NN
cord-307471-zukjh1hr	16	30	)	)	-RRB-
cord-307471-zukjh1hr	16	31	,	,	,
cord-307471-zukjh1hr	16	32	reducing	reduce	VBG
cord-307471-zukjh1hr	16	33	the	the	DT
cord-307471-zukjh1hr	16	34	peak	peak	NN
cord-307471-zukjh1hr	16	35	number	number	NN
cord-307471-zukjh1hr	16	36	of	of	IN
cord-307471-zukjh1hr	16	37	infected	infected	JJ
cord-307471-zukjh1hr	16	38	people	people	NNS
cord-307471-zukjh1hr	16	39	(	(	-LRB-
cord-307471-zukjh1hr	16	40	prevalence	prevalence	NN
cord-307471-zukjh1hr	16	41	)	)	-RRB-
cord-307471-zukjh1hr	16	42	and	and	CC
cord-307471-zukjh1hr	16	43	concomitant	concomitant	JJ
cord-307471-zukjh1hr	16	44	demands	demand	NNS
cord-307471-zukjh1hr	16	45	on	on	IN
cord-307471-zukjh1hr	16	46	healthcare	healthcare	NN
cord-307471-zukjh1hr	16	47	facilities	facility	NNS
cord-307471-zukjh1hr	16	48	and	and	CC
cord-307471-zukjh1hr	16	49	personnel	personnel	NNS
cord-307471-zukjh1hr	16	50	,	,	,
cord-307471-zukjh1hr	16	51	and	and	CC
cord-307471-zukjh1hr	16	52	decreasing	decrease	VBG
cord-307471-zukjh1hr	16	53	overall	overall	JJ
cord-307471-zukjh1hr	16	54	infections	infection	NNS
cord-307471-zukjh1hr	16	55	and	and	CC
cord-307471-zukjh1hr	16	56	deaths	death	NNS
cord-307471-zukjh1hr	16	57	.	.	.
cord-307471-zukjh1hr	17	1	Antimicrobial	antimicrobial	JJ
cord-307471-zukjh1hr	17	2	drugs	drug	NNS
cord-307471-zukjh1hr	17	3	generally	generally	RB
cord-307471-zukjh1hr	17	4	are	be	VBP
cord-307471-zukjh1hr	17	5	administered	administer	VBN
cord-307471-zukjh1hr	17	6	solely	solely	RB
cord-307471-zukjh1hr	17	7	for	for	IN
cord-307471-zukjh1hr	17	8	the	the	DT
cord-307471-zukjh1hr	17	9	benefit	benefit	NN
cord-307471-zukjh1hr	17	10	of	of	IN
cord-307471-zukjh1hr	17	11	individual	individual	JJ
cord-307471-zukjh1hr	17	12	patients	patient	NNS
cord-307471-zukjh1hr	17	13	,	,	,
cord-307471-zukjh1hr	17	14	but	but	CC
cord-307471-zukjh1hr	17	15	may	may	MD
cord-307471-zukjh1hr	17	16	also	also	RB
cord-307471-zukjh1hr	17	17	reduce	reduce	VB
cord-307471-zukjh1hr	17	18	the	the	DT
cord-307471-zukjh1hr	17	19	magnitude	magnitude	NN
cord-307471-zukjh1hr	17	20	or	or	CC
cord-307471-zukjh1hr	17	21	duration	duration	NN
cord-307471-zukjh1hr	17	22	of	of	IN
cord-307471-zukjh1hr	17	23	infectiousness	infectiousness	NN
cord-307471-zukjh1hr	17	24	,	,	,
cord-307471-zukjh1hr	17	25	affecting	affect	VBG
cord-307471-zukjh1hr	17	26	transmission	transmission	NN
cord-307471-zukjh1hr	17	27	to	to	IN
cord-307471-zukjh1hr	17	28	others	other	NNS
cord-307471-zukjh1hr	17	29	.	.	.
cord-307471-zukjh1hr	18	1	Similarly	similarly	RB
cord-307471-zukjh1hr	18	2	,	,	,
cord-307471-zukjh1hr	18	3	vaccines	vaccine	NNS
cord-307471-zukjh1hr	18	4	and	and	CC
cord-307471-zukjh1hr	18	5	monoclonal	monoclonal	JJ
cord-307471-zukjh1hr	18	6	antibodies	antibody	NNS
cord-307471-zukjh1hr	18	7	may	may	MD
cord-307471-zukjh1hr	18	8	reduce	reduce	VB
cord-307471-zukjh1hr	18	9	infectiousness	infectiousness	NN
cord-307471-zukjh1hr	18	10	as	as	RB
cord-307471-zukjh1hr	18	11	well	well	RB
cord-307471-zukjh1hr	18	12	as	as	IN
cord-307471-zukjh1hr	18	13	susceptibility	susceptibility	NN
cord-307471-zukjh1hr	18	14	.	.	.
cord-307471-zukjh1hr	19	1	Accordingly	accordingly	RB
cord-307471-zukjh1hr	19	2	,	,	,
cord-307471-zukjh1hr	19	3	we	-PRON-	PRP
cord-307471-zukjh1hr	19	4	include	include	VBP
cord-307471-zukjh1hr	19	5	pharmaceutical	pharmaceutical	JJ
cord-307471-zukjh1hr	19	6	interventions	intervention	NNS
cord-307471-zukjh1hr	19	7	in	in	IN
cord-307471-zukjh1hr	19	8	our	-PRON-	PRP$
cord-307471-zukjh1hr	19	9	description	description	NN
cord-307471-zukjh1hr	19	10	of	of	IN
cord-307471-zukjh1hr	19	11	mechanisms	mechanism	NNS
cord-307471-zukjh1hr	19	12	underlying	underlie	VBG
cord-307471-zukjh1hr	19	13	efforts	effort	NNS
cord-307471-zukjh1hr	19	14	to	to	TO
cord-307471-zukjh1hr	19	15	flatten	flatten	VB
cord-307471-zukjh1hr	19	16	the	the	DT
cord-307471-zukjh1hr	19	17	curve	curve	NN
cord-307471-zukjh1hr	19	18	.	.	.
cord-307471-zukjh1hr	20	1	Plots	plot	NNS
cord-307471-zukjh1hr	20	2	of	of	IN
cord-307471-zukjh1hr	20	3	daily	daily	JJ
cord-307471-zukjh1hr	20	4	numbers	number	NNS
cord-307471-zukjh1hr	20	5	of	of	IN
cord-307471-zukjh1hr	20	6	new	new	JJ
cord-307471-zukjh1hr	20	7	infections	infection	NNS
cord-307471-zukjh1hr	20	8	,	,	,
cord-307471-zukjh1hr	20	9	called	call	VBN
cord-307471-zukjh1hr	20	10	epidemic	epidemic	NN
cord-307471-zukjh1hr	20	11	curves	curve	NNS
cord-307471-zukjh1hr	20	12	,	,	,
cord-307471-zukjh1hr	20	13	are	be	VBP
cord-307471-zukjh1hr	20	14	affected	affect	VBN
cord-307471-zukjh1hr	20	15	by	by	IN
cord-307471-zukjh1hr	20	16	several	several	JJ
cord-307471-zukjh1hr	20	17	factors	factor	NNS
cord-307471-zukjh1hr	20	18	,	,	,
cord-307471-zukjh1hr	20	19	including	include	VBG
cord-307471-zukjh1hr	20	20	under	under	NN
cord-307471-zukjh1hr	20	21	-	-	HYPH
cord-307471-zukjh1hr	20	22	reporting	reporting	NN
cord-307471-zukjh1hr	20	23	.	.	.
cord-307471-zukjh1hr	21	1	Individual	individual	JJ
cord-307471-zukjh1hr	21	2	responses	response	NNS
cord-307471-zukjh1hr	21	3	to	to	IN
cord-307471-zukjh1hr	21	4	infection	infection	NN
cord-307471-zukjh1hr	21	5	by	by	IN
cord-307471-zukjh1hr	21	6	the	the	DT
cord-307471-zukjh1hr	21	7	same	same	JJ
cord-307471-zukjh1hr	21	8	pathogen	pathogen	NN
cord-307471-zukjh1hr	21	9	differ	differ	VBP
cord-307471-zukjh1hr	21	10	,	,	,
cord-307471-zukjh1hr	21	11	and	and	CC
cord-307471-zukjh1hr	21	12	mild	mild	JJ
cord-307471-zukjh1hr	21	13	infections	infection	NNS
cord-307471-zukjh1hr	21	14	are	be	VBP
cord-307471-zukjh1hr	21	15	less	less	RBR
cord-307471-zukjh1hr	21	16	likely	likely	JJ
cord-307471-zukjh1hr	21	17	to	to	TO
cord-307471-zukjh1hr	21	18	be	be	VB
cord-307471-zukjh1hr	21	19	reported	report	VBN
cord-307471-zukjh1hr	21	20	than	than	IN
cord-307471-zukjh1hr	21	21	those	those	DT
cord-307471-zukjh1hr	21	22	requiring	require	VBG
cord-307471-zukjh1hr	21	23	medical	medical	JJ
cord-307471-zukjh1hr	21	24	attention	attention	NN
cord-307471-zukjh1hr	21	25	.	.	.
cord-307471-zukjh1hr	22	1	Absent	absent	JJ
cord-307471-zukjh1hr	22	2	widespread	widespread	JJ
cord-307471-zukjh1hr	22	3	testing	testing	NN
cord-307471-zukjh1hr	22	4	,	,	,
cord-307471-zukjh1hr	22	5	few	few	JJ
cord-307471-zukjh1hr	22	6	asymptomatic	asymptomatic	JJ
cord-307471-zukjh1hr	22	7	infections	infection	NNS
cord-307471-zukjh1hr	22	8	would	would	MD
cord-307471-zukjh1hr	22	9	be	be	VB
cord-307471-zukjh1hr	22	10	reported	report	VBN
cord-307471-zukjh1hr	22	11	.	.	.
cord-307471-zukjh1hr	23	1	In	in	IN
cord-307471-zukjh1hr	23	2	the	the	DT
cord-307471-zukjh1hr	23	3	ongoing	ongoing	JJ
cord-307471-zukjh1hr	23	4	pandemic	pandemic	NN
cord-307471-zukjh1hr	23	5	,	,	,
cord-307471-zukjh1hr	23	6	people	people	NNS
cord-307471-zukjh1hr	23	7	with	with	IN
cord-307471-zukjh1hr	23	8	few	few	JJ
cord-307471-zukjh1hr	23	9	if	if	IN
cord-307471-zukjh1hr	23	10	any	any	DT
cord-307471-zukjh1hr	23	11	symptoms	symptom	NNS
cord-307471-zukjh1hr	23	12	may	may	MD
cord-307471-zukjh1hr	23	13	be	be	VB
cord-307471-zukjh1hr	23	14	infectious	infectious	JJ
cord-307471-zukjh1hr	23	15	,	,	,
cord-307471-zukjh1hr	23	16	diminishing	diminish	VBG
cord-307471-zukjh1hr	23	17	the	the	DT
cord-307471-zukjh1hr	23	18	effectiveness	effectiveness	NN
cord-307471-zukjh1hr	23	19	of	of	IN
cord-307471-zukjh1hr	23	20	control	control	NN
cord-307471-zukjh1hr	23	21	measures	measure	NNS
cord-307471-zukjh1hr	23	22	based	base	VBN
cord-307471-zukjh1hr	23	23	solely	solely	RB
cord-307471-zukjh1hr	23	24	on	on	IN
cord-307471-zukjh1hr	23	25	symptomatic	symptomatic	JJ
cord-307471-zukjh1hr	23	26	infections	infection	NNS
cord-307471-zukjh1hr	23	27	.	.	.
cord-307471-zukjh1hr	24	1	Social	social	JJ
cord-307471-zukjh1hr	24	2	distancing	distancing	NN
cord-307471-zukjh1hr	25	1	-increasing	-increase	VBG
cord-307471-zukjh1hr	25	2	inter	inter	JJ
cord-307471-zukjh1hr	25	3	-	-	JJ
cord-307471-zukjh1hr	25	4	personal	personal	JJ
cord-307471-zukjh1hr	25	5	distances	distance	NNS
cord-307471-zukjh1hr	25	6	,	,	,
cord-307471-zukjh1hr	25	7	reducing	reduce	VBG
cord-307471-zukjh1hr	25	8	the	the	DT
cord-307471-zukjh1hr	25	9	number	number	NN
cord-307471-zukjh1hr	25	10	of	of	IN
cord-307471-zukjh1hr	25	11	people	people	NNS
cord-307471-zukjh1hr	25	12	attending	attend	VBG
cord-307471-zukjh1hr	25	13	meetingsinvolves	meetingsinvolve	NNS
cord-307471-zukjh1hr	25	14	everyone	everyone	NN
cord-307471-zukjh1hr	25	15	,	,	,
cord-307471-zukjh1hr	25	16	reducing	reduce	VBG
cord-307471-zukjh1hr	25	17	the	the	DT
cord-307471-zukjh1hr	25	18	risks	risk	NNS
cord-307471-zukjh1hr	25	19	of	of	IN
cord-307471-zukjh1hr	25	20	being	be	VBG
cord-307471-zukjh1hr	25	21	infected	infect	VBN
cord-307471-zukjh1hr	25	22	if	if	IN
cord-307471-zukjh1hr	25	23	susceptible	susceptible	JJ
cord-307471-zukjh1hr	25	24	and	and	CC
cord-307471-zukjh1hr	25	25	of	of	IN
cord-307471-zukjh1hr	25	26	infecting	infect	VBG
cord-307471-zukjh1hr	25	27	others	other	NNS
cord-307471-zukjh1hr	25	28	if	if	IN
cord-307471-zukjh1hr	25	29	infectious	infectious	JJ
cord-307471-zukjh1hr	25	30	.	.	.
cord-307471-zukjh1hr	26	1	Assuming	assume	VBG
cord-307471-zukjh1hr	26	2	that	that	IN
cord-307471-zukjh1hr	26	3	infected	infected	JJ
cord-307471-zukjh1hr	26	4	people	people	NNS
cord-307471-zukjh1hr	26	5	are	be	VBP
cord-307471-zukjh1hr	26	6	infectious	infectious	JJ
cord-307471-zukjh1hr	26	7	upon	upon	IN
cord-307471-zukjh1hr	26	8	infection	infection	NN
cord-307471-zukjh1hr	26	9	,	,	,
cord-307471-zukjh1hr	26	10	other	other	JJ
cord-307471-zukjh1hr	26	11	factors	factor	NNS
cord-307471-zukjh1hr	26	12	affecting	affect	VBG
cord-307471-zukjh1hr	26	13	epidemic	epidemic	NN
cord-307471-zukjh1hr	26	14	curves	curve	NNS
cord-307471-zukjh1hr	26	15	are	be	VBP
cord-307471-zukjh1hr	26	16	person	person	NN
cord-307471-zukjh1hr	26	17	-	-	HYPH
cord-307471-zukjh1hr	26	18	to	to	IN
cord-307471-zukjh1hr	26	19	-	-	HYPH
cord-307471-zukjh1hr	26	20	person	person	NN
cord-307471-zukjh1hr	26	21	contact	contact	NN
cord-307471-zukjh1hr	26	22	rates	rate	NNS
cord-307471-zukjh1hr	26	23	(	(	-LRB-
cord-307471-zukjh1hr	26	24	i.e.	i.e.	FW
cord-307471-zukjh1hr	26	25	,	,	,
cord-307471-zukjh1hr	26	26	contacts	contact	NNS
cord-307471-zukjh1hr	26	27	per	per	IN
cord-307471-zukjh1hr	26	28	person	person	NN
cord-307471-zukjh1hr	26	29	per	per	IN
cord-307471-zukjh1hr	26	30	time	time	NN
cord-307471-zukjh1hr	26	31	period	period	NN
cord-307471-zukjh1hr	26	32	)	)	-RRB-
cord-307471-zukjh1hr	26	33	and	and	CC
cord-307471-zukjh1hr	26	34	probabilities	probability	NNS
cord-307471-zukjh1hr	26	35	of	of	IN
cord-307471-zukjh1hr	26	36	infection	infection	NN
cord-307471-zukjh1hr	26	37	on	on	IN
cord-307471-zukjh1hr	26	38	contact	contact	NN
cord-307471-zukjh1hr	26	39	between	between	IN
cord-307471-zukjh1hr	26	40	infectious	infectious	JJ
cord-307471-zukjh1hr	26	41	and	and	CC
cord-307471-zukjh1hr	26	42	susceptible	susceptible	JJ
cord-307471-zukjh1hr	26	43	people	people	NNS
cord-307471-zukjh1hr	26	44	,	,	,
cord-307471-zukjh1hr	26	45	or	or	CC
cord-307471-zukjh1hr	26	46	infectiousness	infectiousness	NN
cord-307471-zukjh1hr	26	47	.	.	.
cord-307471-zukjh1hr	27	1	The	the	DT
cord-307471-zukjh1hr	27	2	sum	sum	NN
cord-307471-zukjh1hr	27	3	of	of	IN
cord-307471-zukjh1hr	27	4	contacts	contact	NNS
cord-307471-zukjh1hr	27	5	by	by	IN
cord-307471-zukjh1hr	27	6	which	which	WDT
cord-307471-zukjh1hr	27	7	susceptible	susceptible	JJ
cord-307471-zukjh1hr	27	8	people	people	NNS
cord-307471-zukjh1hr	27	9	would	would	MD
cord-307471-zukjh1hr	27	10	be	be	VB
cord-307471-zukjh1hr	27	11	infected	infect	VBN
cord-307471-zukjh1hr	27	12	,	,	,
cord-307471-zukjh1hr	27	13	which	which	WDT
cord-307471-zukjh1hr	27	14	are	be	VBP
cord-307471-zukjh1hr	27	15	products	product	NNS
cord-307471-zukjh1hr	27	16	of	of	IN
cord-307471-zukjh1hr	27	17	these	these	DT
cord-307471-zukjh1hr	27	18	rates	rate	NNS
cord-307471-zukjh1hr	27	19	and	and	CC
cord-307471-zukjh1hr	27	20	probabilities	probability	NNS
cord-307471-zukjh1hr	27	21	(	(	-LRB-
cord-307471-zukjh1hr	27	22	Hethcote	Hethcote	NNP
cord-307471-zukjh1hr	27	23	2000	2000	CD
cord-307471-zukjh1hr	27	24	)	)	-RRB-
cord-307471-zukjh1hr	27	25	,	,	,
cord-307471-zukjh1hr	27	26	estimates	estimate	VBZ
cord-307471-zukjh1hr	27	27	the	the	DT
cord-307471-zukjh1hr	27	28	basic	basic	JJ
cord-307471-zukjh1hr	27	29	reproduction	reproduction	NN
cord-307471-zukjh1hr	27	30	number	number	NN
cord-307471-zukjh1hr	27	31	,	,	,
cord-307471-zukjh1hr	27	32	or	or	CC
cord-307471-zukjh1hr	27	33	average	average	JJ
cord-307471-zukjh1hr	27	34	number	number	NN
cord-307471-zukjh1hr	27	35	of	of	IN
cord-307471-zukjh1hr	27	36	secondary	secondary	JJ
cord-307471-zukjh1hr	27	37	infections	infection	NNS
cord-307471-zukjh1hr	27	38	per	per	IN
cord-307471-zukjh1hr	27	39	infected	infected	JJ
cord-307471-zukjh1hr	27	40	person	person	NN
cord-307471-zukjh1hr	27	41	.	.	.
cord-307471-zukjh1hr	28	1	The	the	DT
cord-307471-zukjh1hr	28	2	areas	area	NNS
cord-307471-zukjh1hr	28	3	beneath	beneath	IN
cord-307471-zukjh1hr	28	4	epidemic	epidemic	NN
cord-307471-zukjh1hr	28	5	curves	curve	NNS
cord-307471-zukjh1hr	28	6	represent	represent	VBP
cord-307471-zukjh1hr	28	7	total	total	JJ
cord-307471-zukjh1hr	28	8	numbers	number	NNS
cord-307471-zukjh1hr	28	9	of	of	IN
cord-307471-zukjh1hr	28	10	infections	infection	NNS
cord-307471-zukjh1hr	28	11	.	.	.
cord-307471-zukjh1hr	29	1	The	the	DT
cord-307471-zukjh1hr	29	2	onset	onset	NN
cord-307471-zukjh1hr	29	3	,	,	,
cord-307471-zukjh1hr	29	4	shape	shape	NN
cord-307471-zukjh1hr	29	5	and	and	CC
cord-307471-zukjh1hr	29	6	area	area	NN
cord-307471-zukjh1hr	29	7	beneath	beneath	IN
cord-307471-zukjh1hr	29	8	these	these	DT
cord-307471-zukjh1hr	29	9	curves	curve	NNS
cord-307471-zukjh1hr	29	10	all	all	DT
cord-307471-zukjh1hr	29	11	depend	depend	VBP
cord-307471-zukjh1hr	29	12	on	on	IN
cord-307471-zukjh1hr	29	13	the	the	DT
cord-307471-zukjh1hr	29	14	basic	basic	JJ
cord-307471-zukjh1hr	29	15	reproduction	reproduction	NN
cord-307471-zukjh1hr	29	16	number	number	NN
cord-307471-zukjh1hr	29	17	,	,	,
cord-307471-zukjh1hr	29	18	which	which	WDT
cord-307471-zukjh1hr	29	19	must	must	MD
cord-307471-zukjh1hr	29	20	be	be	VB
cord-307471-zukjh1hr	29	21	greater	great	JJR
cord-307471-zukjh1hr	29	22	than	than	IN
cord-307471-zukjh1hr	29	23	one	one	CD
cord-307471-zukjh1hr	29	24	for	for	IN
cord-307471-zukjh1hr	29	25	epidemics	epidemic	NNS
cord-307471-zukjh1hr	29	26	to	to	TO
cord-307471-zukjh1hr	29	27	occur	occur	VB
cord-307471-zukjh1hr	29	28	.	.	.
cord-307471-zukjh1hr	30	1	The	the	DT
cord-307471-zukjh1hr	30	2	smaller	small	JJR
cord-307471-zukjh1hr	30	3	this	this	DT
cord-307471-zukjh1hr	30	4	number	number	NN
cord-307471-zukjh1hr	30	5	,	,	,
cord-307471-zukjh1hr	30	6	the	the	DT
cord-307471-zukjh1hr	30	7	longer	long	RBR
cord-307471-zukjh1hr	30	8	the	the	DT
cord-307471-zukjh1hr	30	9	delay	delay	NN
cord-307471-zukjh1hr	30	10	to	to	TO
cord-307471-zukjh1hr	30	11	peak	peak	VB
cord-307471-zukjh1hr	30	12	incidence	incidence	NN
cord-307471-zukjh1hr	30	13	,	,	,
cord-307471-zukjh1hr	30	14	the	the	DT
cord-307471-zukjh1hr	30	15	lower	low	JJR
cord-307471-zukjh1hr	30	16	the	the	DT
cord-307471-zukjh1hr	30	17	peak	peak	NN
cord-307471-zukjh1hr	30	18	,	,	,
cord-307471-zukjh1hr	30	19	and	and	CC
cord-307471-zukjh1hr	30	20	fewer	few	JJR
cord-307471-zukjh1hr	30	21	the	the	DT
cord-307471-zukjh1hr	30	22	total	total	JJ
cord-307471-zukjh1hr	30	23	number	number	NN
cord-307471-zukjh1hr	30	24	of	of	IN
cord-307471-zukjh1hr	30	25	infections	infection	NNS
cord-307471-zukjh1hr	30	26	(	(	-LRB-
cord-307471-zukjh1hr	30	27	figure	figure	NN
cord-307471-zukjh1hr	30	28	1	1	CD
cord-307471-zukjh1hr	30	29	)	)	-RRB-
cord-307471-zukjh1hr	30	30	.	.	.
cord-307471-zukjh1hr	31	1	Both	both	DT
cord-307471-zukjh1hr	31	2	of	of	IN
cord-307471-zukjh1hr	31	3	the	the	DT
cord-307471-zukjh1hr	31	4	basic	basic	JJ
cord-307471-zukjh1hr	31	5	reproduction	reproduction	NN
cord-307471-zukjh1hr	31	6	number	number	NN
cord-307471-zukjh1hr	31	7	's	's	POS
cord-307471-zukjh1hr	31	8	constituents	constituent	NNS
cord-307471-zukjh1hr	31	9	may	may	MD
cord-307471-zukjh1hr	31	10	be	be	VB
cord-307471-zukjh1hr	31	11	modifiable	modifiable	JJ
cord-307471-zukjh1hr	31	12	,	,	,
cord-307471-zukjh1hr	31	13	contact	contact	NN
cord-307471-zukjh1hr	31	14	rates	rate	NNS
cord-307471-zukjh1hr	31	15	by	by	IN
cord-307471-zukjh1hr	31	16	social	social	JJ
cord-307471-zukjh1hr	31	17	distancing	distancing	NN
cord-307471-zukjh1hr	31	18	and	and	CC
cord-307471-zukjh1hr	31	19	infectiousness	infectiousness	NN
cord-307471-zukjh1hr	31	20	by	by	IN
cord-307471-zukjh1hr	31	21	medications	medication	NNS
cord-307471-zukjh1hr	31	22	,	,	,
cord-307471-zukjh1hr	31	23	whereupon	whereupon	RB
cord-307471-zukjh1hr	31	24	they	-PRON-	PRP
cord-307471-zukjh1hr	31	25	would	would	MD
cord-307471-zukjh1hr	31	26	be	be	VB
cord-307471-zukjh1hr	31	27	termed	term	VBN
cord-307471-zukjh1hr	31	28	effective	effective	JJ
cord-307471-zukjh1hr	31	29	reproduction	reproduction	NN
cord-307471-zukjh1hr	31	30	numbers	number	NNS
cord-307471-zukjh1hr	31	31	.	.	.
cord-307471-zukjh1hr	32	1	Figure	figure	NN
cord-307471-zukjh1hr	32	2	1	1	CD
cord-307471-zukjh1hr	32	3	.	.	.
cord-307471-zukjh1hr	33	1	Epidemic	epidemic	NN
cord-307471-zukjh1hr	33	2	curves	curve	NNS
cord-307471-zukjh1hr	33	3	with	with	IN
cord-307471-zukjh1hr	33	4	varying	vary	VBG
cord-307471-zukjh1hr	33	5	contact	contact	NN
cord-307471-zukjh1hr	33	6	rates	rate	NNS
cord-307471-zukjh1hr	33	7	.	.	.
cord-307471-zukjh1hr	34	1	The	the	DT
cord-307471-zukjh1hr	34	2	contact	contact	NN
cord-307471-zukjh1hr	34	3	rates	rate	NNS
cord-307471-zukjh1hr	34	4	decrease	decrease	VBP
cord-307471-zukjh1hr	34	5	by	by	IN
cord-307471-zukjh1hr	34	6	1	1	CD
cord-307471-zukjh1hr	34	7	from	from	IN
cord-307471-zukjh1hr	34	8	10	10	CD
cord-307471-zukjh1hr	34	9	to	to	TO
cord-307471-zukjh1hr	34	10	6	6	CD
cord-307471-zukjh1hr	34	11	per	per	IN
cord-307471-zukjh1hr	34	12	day	day	NN
cord-307471-zukjh1hr	34	13	(	(	-LRB-
cord-307471-zukjh1hr	34	14	left	leave	VBN
cord-307471-zukjh1hr	34	15	to	to	IN
cord-307471-zukjh1hr	34	16	right	right	NN
cord-307471-zukjh1hr	34	17	)	)	-RRB-
cord-307471-zukjh1hr	34	18	,	,	,
cord-307471-zukjh1hr	34	19	corresponding	correspond	VBG
cord-307471-zukjh1hr	34	20	to	to	IN
cord-307471-zukjh1hr	34	21	reproduction	reproduction	NN
cord-307471-zukjh1hr	34	22	numbers	number	NNS
cord-307471-zukjh1hr	34	23	ranging	range	VBG
cord-307471-zukjh1hr	34	24	from	from	IN
cord-307471-zukjh1hr	34	25	2.5	2.5	CD
cord-307471-zukjh1hr	34	26	to	to	IN
cord-307471-zukjh1hr	34	27	1.5	1.5	CD
cord-307471-zukjh1hr	34	28	.	.	.
cord-307471-zukjh1hr	35	1	As	as	IN
cord-307471-zukjh1hr	35	2	these	these	DT
cord-307471-zukjh1hr	35	3	numbers	number	NNS
cord-307471-zukjh1hr	35	4	decrease	decrease	VBP
cord-307471-zukjh1hr	35	5	,	,	,
cord-307471-zukjh1hr	35	6	the	the	DT
cord-307471-zukjh1hr	35	7	percent	percent	NN
cord-307471-zukjh1hr	35	8	of	of	IN
cord-307471-zukjh1hr	35	9	the	the	DT
cord-307471-zukjh1hr	35	10	population	population	NN
cord-307471-zukjh1hr	35	11	infected	infect	VBN
cord-307471-zukjh1hr	35	12	decreases	decrease	NNS
cord-307471-zukjh1hr	35	13	from	from	IN
cord-307471-zukjh1hr	35	14	89	89	CD
cord-307471-zukjh1hr	35	15	%	%	NN
cord-307471-zukjh1hr	35	16	to	to	IN
cord-307471-zukjh1hr	35	17	58	58	CD
cord-307471-zukjh1hr	35	18	%	%	NN
cord-307471-zukjh1hr	35	19	.	.	.
cord-307471-zukjh1hr	36	1	Thus	thus	RB
cord-307471-zukjh1hr	36	2	,	,	,
cord-307471-zukjh1hr	36	3	social	social	JJ
cord-307471-zukjh1hr	36	4	distancing	distance	VBG
cord-307471-zukjh1hr	36	5	not	not	RB
cord-307471-zukjh1hr	36	6	only	only	RB
cord-307471-zukjh1hr	36	7	delays	delay	NNS
cord-307471-zukjh1hr	36	8	and	and	CC
cord-307471-zukjh1hr	36	9	diminishes	diminish	VBZ
cord-307471-zukjh1hr	36	10	the	the	DT
cord-307471-zukjh1hr	36	11	peak	peak	NN
cord-307471-zukjh1hr	36	12	number	number	NN
cord-307471-zukjh1hr	36	13	of	of	IN
cord-307471-zukjh1hr	36	14	infections	infection	NNS
cord-307471-zukjh1hr	36	15	,	,	,
cord-307471-zukjh1hr	36	16	it	-PRON-	PRP
cord-307471-zukjh1hr	36	17	also	also	RB
cord-307471-zukjh1hr	36	18	reduces	reduce	VBZ
cord-307471-zukjh1hr	36	19	the	the	DT
cord-307471-zukjh1hr	36	20	total	total	JJ
cord-307471-zukjh1hr	36	21	number	number	NN
cord-307471-zukjh1hr	36	22	of	of	IN
cord-307471-zukjh1hr	36	23	infections	infection	NNS
cord-307471-zukjh1hr	36	24	.	.	.
cord-307471-zukjh1hr	37	1	While	while	IN
cord-307471-zukjh1hr	37	2	drugs	drug	NNS
cord-307471-zukjh1hr	37	3	are	be	VBP
cord-307471-zukjh1hr	37	4	administered	administer	VBN
cord-307471-zukjh1hr	37	5	to	to	TO
cord-307471-zukjh1hr	37	6	cure	cure	VB
cord-307471-zukjh1hr	37	7	infections	infection	NNS
cord-307471-zukjh1hr	37	8	or	or	CC
cord-307471-zukjh1hr	37	9	mitigate	mitigate	VB
cord-307471-zukjh1hr	37	10	symptoms	symptom	NNS
cord-307471-zukjh1hr	37	11	,	,	,
cord-307471-zukjh1hr	37	12	they	-PRON-	PRP
cord-307471-zukjh1hr	37	13	may	may	MD
cord-307471-zukjh1hr	37	14	also	also	RB
cord-307471-zukjh1hr	37	15	affect	affect	VB
cord-307471-zukjh1hr	37	16	the	the	DT
cord-307471-zukjh1hr	37	17	magnitude	magnitude	NN
cord-307471-zukjh1hr	37	18	or	or	CC
cord-307471-zukjh1hr	37	19	duration	duration	NN
cord-307471-zukjh1hr	37	20	of	of	IN
cord-307471-zukjh1hr	37	21	infectiousness	infectiousness	NN
cord-307471-zukjh1hr	37	22	.	.	.
cord-307471-zukjh1hr	38	1	Clinical	clinical	JJ
cord-307471-zukjh1hr	38	2	trials	trial	NNS
cord-307471-zukjh1hr	38	3	of	of	IN
cord-307471-zukjh1hr	38	4	remdesivir	remdesivir	NNP
cord-307471-zukjh1hr	38	5	and	and	CC
cord-307471-zukjh1hr	38	6	other	other	JJ
cord-307471-zukjh1hr	38	7	promising	promising	JJ
cord-307471-zukjh1hr	38	8	antiviral	antiviral	JJ
cord-307471-zukjh1hr	38	9	drugs	drug	NNS
cord-307471-zukjh1hr	38	10	are	be	VBP
cord-307471-zukjh1hr	38	11	underway	underway	JJ
cord-307471-zukjh1hr	38	12	(	(	-LRB-
cord-307471-zukjh1hr	38	13	https://clinicaltrials.gov/ct2/results?cond=COVID-19	https://clinicaltrials.gov/ct2/results?cond=COVID-19	NNP
cord-307471-zukjh1hr	38	14	)	)	-RRB-
cord-307471-zukjh1hr	38	15	,	,	,
cord-307471-zukjh1hr	38	16	but	but	CC
cord-307471-zukjh1hr	38	17	none	none	NN
cord-307471-zukjh1hr	38	18	has	have	VBZ
cord-307471-zukjh1hr	38	19	yet	yet	RB
cord-307471-zukjh1hr	38	20	been	be	VBN
cord-307471-zukjh1hr	38	21	proven	prove	VBN
cord-307471-zukjh1hr	38	22	effective	effective	JJ
cord-307471-zukjh1hr	38	23	against	against	IN
cord-307471-zukjh1hr	38	24	SARS	SARS	NNP
cord-307471-zukjh1hr	38	25	-	-	HYPH
cord-307471-zukjh1hr	38	26	CoV-2	CoV-2	NNP
cord-307471-zukjh1hr	38	27	.	.	.
cord-307471-zukjh1hr	39	1	This	this	DT
cord-307471-zukjh1hr	39	2	is	be	VBZ
cord-307471-zukjh1hr	39	3	the	the	DT
cord-307471-zukjh1hr	39	4	mechanism	mechanism	NN
cord-307471-zukjh1hr	39	5	underlying	underlie	VBG
cord-307471-zukjh1hr	39	6	the	the	DT
cord-307471-zukjh1hr	39	7	"	"	``
cord-307471-zukjh1hr	39	8	treatment	treatment	NN
cord-307471-zukjh1hr	39	9	as	as	IN
cord-307471-zukjh1hr	39	10	prevention	prevention	NN
cord-307471-zukjh1hr	39	11	"	"	''
cord-307471-zukjh1hr	39	12	approach	approach	NN
cord-307471-zukjh1hr	39	13	to	to	IN
cord-307471-zukjh1hr	39	14	reducing	reduce	VBG
cord-307471-zukjh1hr	39	15	HIV	HIV	NNP
cord-307471-zukjh1hr	39	16	infection	infection	NN
cord-307471-zukjh1hr	39	17	rates	rate	NNS
cord-307471-zukjh1hr	39	18	.	.	.
cord-307471-zukjh1hr	40	1	Treatment	treatment	NN
cord-307471-zukjh1hr	40	2	of	of	IN
cord-307471-zukjh1hr	40	3	infected	infected	JJ
cord-307471-zukjh1hr	40	4	people	people	NNS
cord-307471-zukjh1hr	40	5	with	with	IN
cord-307471-zukjh1hr	40	6	anti	anti	JJ
cord-307471-zukjh1hr	40	7	-	-	JJ
cord-307471-zukjh1hr	40	8	retroviral	retroviral	JJ
cord-307471-zukjh1hr	40	9	drugs	drug	NNS
cord-307471-zukjh1hr	40	10	reduces	reduce	VBZ
cord-307471-zukjh1hr	40	11	their	-PRON-	PRP$
cord-307471-zukjh1hr	40	12	viral	viral	JJ
cord-307471-zukjh1hr	40	13	load	load	NN
cord-307471-zukjh1hr	40	14	,	,	,
cord-307471-zukjh1hr	40	15	preventing	prevent	VBG
cord-307471-zukjh1hr	40	16	their	-PRON-	PRP$
cord-307471-zukjh1hr	40	17	progression	progression	NN
cord-307471-zukjh1hr	40	18	to	to	IN
cord-307471-zukjh1hr	40	19	AIDS	AIDS	NNP
cord-307471-zukjh1hr	40	20	.	.	.
cord-307471-zukjh1hr	41	1	Authorities	authority	NNS
cord-307471-zukjh1hr	41	2	believe	believe	VBP
cord-307471-zukjh1hr	41	3	that	that	IN
cord-307471-zukjh1hr	41	4	it	-PRON-	PRP
cord-307471-zukjh1hr	41	5	also	also	RB
cord-307471-zukjh1hr	41	6	reduces	reduce	VBZ
cord-307471-zukjh1hr	41	7	their	-PRON-	PRP$
cord-307471-zukjh1hr	41	8	infectiousness	infectiousness	NN
cord-307471-zukjh1hr	41	9	,	,	,
cord-307471-zukjh1hr	41	10	which	which	WDT
cord-307471-zukjh1hr	41	11	would	would	MD
cord-307471-zukjh1hr	41	12	lower	lower	VB
cord-307471-zukjh1hr	41	13	the	the	DT
cord-307471-zukjh1hr	41	14	effective	effective	JJ
cord-307471-zukjh1hr	41	15	reproduction	reproduction	NN
cord-307471-zukjh1hr	41	16	number	number	NN
cord-307471-zukjh1hr	41	17	.	.	.
cord-307471-zukjh1hr	42	1	This	this	DT
cord-307471-zukjh1hr	42	2	is	be	VBZ
cord-307471-zukjh1hr	42	3	the	the	DT
cord-307471-zukjh1hr	42	4	rationale	rationale	NN
cord-307471-zukjh1hr	42	5	for	for	IN
cord-307471-zukjh1hr	42	6	the	the	DT
cord-307471-zukjh1hr	42	7	US	US	NNP
cord-307471-zukjh1hr	42	8	national	national	JJ
cord-307471-zukjh1hr	42	9	initiative	initiative	NN
cord-307471-zukjh1hr	42	10	,	,	,
cord-307471-zukjh1hr	42	11	"	"	``
cord-307471-zukjh1hr	42	12	Ending	end	VBG
cord-307471-zukjh1hr	42	13	the	the	DT
cord-307471-zukjh1hr	42	14	HIV	HIV	NNP
cord-307471-zukjh1hr	42	15	Epidemic	Epidemic	NNP
cord-307471-zukjh1hr	42	16	:	:	:
cord-307471-zukjh1hr	42	17	A	a	DT
cord-307471-zukjh1hr	42	18	Plan	Plan	NNP
cord-307471-zukjh1hr	42	19	for	for	IN
cord-307471-zukjh1hr	42	20	America	America	NNP
cord-307471-zukjh1hr	42	21	"	"	''
cord-307471-zukjh1hr	42	22	(	(	-LRB-
cord-307471-zukjh1hr	42	23	https://www.hiv.gov/federal-response/ending-the-hiv-epidemic/overview	https://www.hiv.gov/federal-response/ending-the-hiv-epidemic/overview	NN
cord-307471-zukjh1hr	42	24	)	)	-RRB-
cord-307471-zukjh1hr	42	25	.	.	.
cord-307471-zukjh1hr	43	1	Similarly	similarly	RB
cord-307471-zukjh1hr	43	2	,	,	,
cord-307471-zukjh1hr	43	3	unprecedented	unprecedented	JJ
cord-307471-zukjh1hr	43	4	efforts	effort	NNS
cord-307471-zukjh1hr	43	5	to	to	TO
cord-307471-zukjh1hr	43	6	develop	develop	VB
cord-307471-zukjh1hr	43	7	vaccines	vaccine	NNS
cord-307471-zukjh1hr	43	8	(	(	-LRB-
cord-307471-zukjh1hr	43	9	Le	Le	NNP
cord-307471-zukjh1hr	43	10	et	et	FW
cord-307471-zukjh1hr	43	11	al	al	NNP
cord-307471-zukjh1hr	43	12	.	.	NNP
cord-307471-zukjh1hr	43	13	2020	2020	CD
cord-307471-zukjh1hr	43	14	)	)	-RRB-
cord-307471-zukjh1hr	43	15	or	or	CC
cord-307471-zukjh1hr	43	16	monoclonal	monoclonal	JJ
cord-307471-zukjh1hr	43	17	antibodies	antibody	NNS
cord-307471-zukjh1hr	43	18	(	(	-LRB-
cord-307471-zukjh1hr	44	1	e.g.	e.g.	RB
cord-307471-zukjh1hr	44	2	,	,	,
cord-307471-zukjh1hr	44	3	Wang	Wang	NNP
cord-307471-zukjh1hr	44	4	et	et	NNP
cord-307471-zukjh1hr	44	5	al	al	NNP
cord-307471-zukjh1hr	44	6	.	.	NNP
cord-307471-zukjh1hr	44	7	2020	2020	CD
cord-307471-zukjh1hr	44	8	)	)	-RRB-
cord-307471-zukjh1hr	44	9	against	against	IN
cord-307471-zukjh1hr	44	10	SARS	SARS	NNP
cord-307471-zukjh1hr	44	11	-	-	HYPH
cord-307471-zukjh1hr	44	12	CoV-2	CoV-2	NNP
cord-307471-zukjh1hr	44	13	also	also	RB
cord-307471-zukjh1hr	44	14	are	be	VBP
cord-307471-zukjh1hr	44	15	underway	underway	JJ
cord-307471-zukjh1hr	44	16	.	.	.
cord-307471-zukjh1hr	45	1	Should	Should	MD
cord-307471-zukjh1hr	45	2	any	any	DT
cord-307471-zukjh1hr	45	3	prove	prove	VB
cord-307471-zukjh1hr	45	4	safe	safe	JJ
cord-307471-zukjh1hr	45	5	and	and	CC
cord-307471-zukjh1hr	45	6	effective	effective	JJ
cord-307471-zukjh1hr	45	7	,	,	,
cord-307471-zukjh1hr	45	8	they	-PRON-	PRP
cord-307471-zukjh1hr	45	9	may	may	MD
cord-307471-zukjh1hr	45	10	reduce	reduce	VB
cord-307471-zukjh1hr	45	11	infectiousness	infectiousness	NN
cord-307471-zukjh1hr	45	12	as	as	RB
cord-307471-zukjh1hr	45	13	well	well	RB
cord-307471-zukjh1hr	45	14	as	as	IN
cord-307471-zukjh1hr	45	15	susceptibility	susceptibility	NN
cord-307471-zukjh1hr	45	16	to	to	IN
cord-307471-zukjh1hr	45	17	infection	infection	NN
cord-307471-zukjh1hr	45	18	.	.	.
cord-307471-zukjh1hr	46	1	But	but	CC
cord-307471-zukjh1hr	46	2	the	the	DT
cord-307471-zukjh1hr	46	3	only	only	JJ
cord-307471-zukjh1hr	46	4	way	way	NN
cord-307471-zukjh1hr	46	5	to	to	TO
cord-307471-zukjh1hr	46	6	flatten	flatten	VB
cord-307471-zukjh1hr	46	7	epidemic	epidemic	NN
cord-307471-zukjh1hr	46	8	curves	curve	NNS
cord-307471-zukjh1hr	46	9	without	without	IN
cord-307471-zukjh1hr	46	10	also	also	RB
cord-307471-zukjh1hr	46	11	affecting	affect	VBG
cord-307471-zukjh1hr	46	12	the	the	DT
cord-307471-zukjh1hr	46	13	areas	area	NNS
cord-307471-zukjh1hr	46	14	beneath	beneath	IN
cord-307471-zukjh1hr	46	15	them	-PRON-	PRP
cord-307471-zukjh1hr	46	16	-as	-as	NFP
cord-307471-zukjh1hr	46	17	some	some	DT
cord-307471-zukjh1hr	46	18	figures	figure	NNS
cord-307471-zukjh1hr	46	19	in	in	IN
cord-307471-zukjh1hr	46	20	the	the	DT
cord-307471-zukjh1hr	46	21	media	medium	NNS
cord-307471-zukjh1hr	46	22	have	have	VBP
cord-307471-zukjh1hr	46	23	suggested	suggest	VBN
cord-307471-zukjh1hr	46	24	-is	-is	:
cord-307471-zukjh1hr	46	25	to	to	TO
cord-307471-zukjh1hr	46	26	change	change	VB
cord-307471-zukjh1hr	46	27	the	the	DT
cord-307471-zukjh1hr	46	28	mean	mean	JJ
cord-307471-zukjh1hr	46	29	interval	interval	NN
cord-307471-zukjh1hr	46	30	between	between	IN
cord-307471-zukjh1hr	46	31	being	be	VBG
cord-307471-zukjh1hr	46	32	infected	infect	VBN
cord-307471-zukjh1hr	46	33	and	and	CC
cord-307471-zukjh1hr	46	34	infecting	infect	VBG
cord-307471-zukjh1hr	46	35	others	other	NNS
cord-307471-zukjh1hr	46	36	,	,	,
cord-307471-zukjh1hr	46	37	or	or	CC
cord-307471-zukjh1hr	46	38	generation	generation	NN
cord-307471-zukjh1hr	46	39	time	time	NN
cord-307471-zukjh1hr	46	40	.	.	.
cord-307471-zukjh1hr	47	1	The	the	DT
cord-307471-zukjh1hr	47	2	pathogenesis	pathogenesis	NN
cord-307471-zukjh1hr	47	3	of	of	IN
cord-307471-zukjh1hr	47	4	infectious	infectious	JJ
cord-307471-zukjh1hr	47	5	diseases	disease	NNS
cord-307471-zukjh1hr	47	6	typically	typically	RB
cord-307471-zukjh1hr	47	7	is	be	VBZ
cord-307471-zukjh1hr	47	8	characterized	characterize	VBN
cord-307471-zukjh1hr	47	9	by	by	IN
cord-307471-zukjh1hr	47	10	replication	replication	NN
cord-307471-zukjh1hr	47	11	prior	prior	RB
cord-307471-zukjh1hr	47	12	to	to	IN
cord-307471-zukjh1hr	47	13	dissemination	dissemination	NN
cord-307471-zukjh1hr	48	1	(	(	-LRB-
cord-307471-zukjh1hr	48	2	Nash	Nash	NNP
cord-307471-zukjh1hr	48	3	et	et	NNP
cord-307471-zukjh1hr	48	4	al	al	NNP
cord-307471-zukjh1hr	48	5	.	.	NNP
cord-307471-zukjh1hr	48	6	2015	2015	CD
cord-307471-zukjh1hr	48	7	)	)	-RRB-
cord-307471-zukjh1hr	48	8	,	,	,
cord-307471-zukjh1hr	48	9	so	so	IN
cord-307471-zukjh1hr	48	10	that	that	IN
cord-307471-zukjh1hr	48	11	people	people	NNS
cord-307471-zukjh1hr	48	12	are	be	VBP
cord-307471-zukjh1hr	48	13	not	not	RB
cord-307471-zukjh1hr	48	14	infectious	infectious	JJ
cord-307471-zukjh1hr	48	15	for	for	IN
cord-307471-zukjh1hr	48	16	a	a	DT
cord-307471-zukjh1hr	48	17	while	while	NN
cord-307471-zukjh1hr	48	18	after	after	IN
cord-307471-zukjh1hr	48	19	being	be	VBG
cord-307471-zukjh1hr	48	20	infected	infect	VBN
cord-307471-zukjh1hr	48	21	,	,	,
cord-307471-zukjh1hr	48	22	called	call	VBN
cord-307471-zukjh1hr	48	23	the	the	DT
cord-307471-zukjh1hr	48	24	latent	latent	JJ
cord-307471-zukjh1hr	48	25	period	period	NN
cord-307471-zukjh1hr	48	26	.	.	.
cord-307471-zukjh1hr	49	1	Suppose	suppose	VB
cord-307471-zukjh1hr	49	2	-for	-for	HYPH
cord-307471-zukjh1hr	49	3	sake	sake	NN
cord-307471-zukjh1hr	49	4	of	of	IN
cord-307471-zukjh1hr	49	5	argument	argument	NN
cord-307471-zukjh1hr	50	1	-that	-that	.
cord-307471-zukjh1hr	51	1	we	-PRON-	PRP
cord-307471-zukjh1hr	51	2	could	could	MD
cord-307471-zukjh1hr	51	3	modify	modify	VB
cord-307471-zukjh1hr	51	4	this	this	DT
cord-307471-zukjh1hr	51	5	period	period	NN
cord-307471-zukjh1hr	51	6	(	(	-LRB-
cord-307471-zukjh1hr	51	7	figure	figure	NN
cord-307471-zukjh1hr	51	8	2	2	CD
cord-307471-zukjh1hr	51	9	)	)	-RRB-
cord-307471-zukjh1hr	51	10	.	.	.
cord-307471-zukjh1hr	52	1	Figure	figure	NN
cord-307471-zukjh1hr	52	2	2	2	CD
cord-307471-zukjh1hr	52	3	.	.	.
cord-307471-zukjh1hr	53	1	Epidemic	epidemic	NN
cord-307471-zukjh1hr	53	2	curves	curve	NNS
cord-307471-zukjh1hr	53	3	with	with	IN
cord-307471-zukjh1hr	53	4	varying	vary	VBG
cord-307471-zukjh1hr	53	5	latency	latency	NN
cord-307471-zukjh1hr	53	6	.	.	.
cord-307471-zukjh1hr	54	1	Intervals	interval	NNS
cord-307471-zukjh1hr	54	2	from	from	IN
cord-307471-zukjh1hr	54	3	infection	infection	NN
cord-307471-zukjh1hr	54	4	to	to	IN
cord-307471-zukjh1hr	54	5	the	the	DT
cord-307471-zukjh1hr	54	6	onset	onset	NN
cord-307471-zukjh1hr	54	7	of	of	IN
cord-307471-zukjh1hr	54	8	infectiousness	infectiousness	NN
cord-307471-zukjh1hr	54	9	or	or	CC
cord-307471-zukjh1hr	54	10	latent	latent	JJ
cord-307471-zukjh1hr	54	11	periods	period	NNS
cord-307471-zukjh1hr	54	12	increase	increase	VBP
cord-307471-zukjh1hr	54	13	from	from	IN
cord-307471-zukjh1hr	54	14	10	10	CD
cord-307471-zukjh1hr	54	15	to	to	TO
cord-307471-zukjh1hr	54	16	26	26	CD
cord-307471-zukjh1hr	54	17	in	in	IN
cord-307471-zukjh1hr	54	18	4-day	4-day	JJ
cord-307471-zukjh1hr	54	19	increments	increment	NNS
cord-307471-zukjh1hr	54	20	(	(	-LRB-
cord-307471-zukjh1hr	54	21	left	leave	VBN
cord-307471-zukjh1hr	54	22	to	to	IN
cord-307471-zukjh1hr	54	23	right	right	NN
cord-307471-zukjh1hr	54	24	)	)	-RRB-
cord-307471-zukjh1hr	54	25	,	,	,
cord-307471-zukjh1hr	54	26	all	all	DT
cord-307471-zukjh1hr	54	27	corresponding	correspond	VBG
cord-307471-zukjh1hr	54	28	to	to	IN
cord-307471-zukjh1hr	54	29	a	a	DT
cord-307471-zukjh1hr	54	30	basic	basic	JJ
cord-307471-zukjh1hr	54	31	reproduction	reproduction	NN
cord-307471-zukjh1hr	54	32	number	number	NN
cord-307471-zukjh1hr	54	33	of	of	IN
cord-307471-zukjh1hr	54	34	2.5	2.5	CD
cord-307471-zukjh1hr	54	35	.	.	.
cord-307471-zukjh1hr	55	1	Note	note	VB
cord-307471-zukjh1hr	55	2	that	that	IN
cord-307471-zukjh1hr	55	3	the	the	DT
cord-307471-zukjh1hr	55	4	thick	thick	JJ
cord-307471-zukjh1hr	55	5	red	red	JJ
cord-307471-zukjh1hr	55	6	curves	curve	NNS
cord-307471-zukjh1hr	55	7	are	be	VBP
cord-307471-zukjh1hr	55	8	identical	identical	JJ
cord-307471-zukjh1hr	55	9	in	in	IN
cord-307471-zukjh1hr	55	10	both	both	DT
cord-307471-zukjh1hr	55	11	figures	figure	NNS
cord-307471-zukjh1hr	55	12	and	and	CC
cord-307471-zukjh1hr	55	13	that	that	IN
cord-307471-zukjh1hr	55	14	,	,	,
cord-307471-zukjh1hr	55	15	in	in	IN
cord-307471-zukjh1hr	55	16	this	this	DT
cord-307471-zukjh1hr	55	17	one	one	NN
cord-307471-zukjh1hr	55	18	,	,	,
cord-307471-zukjh1hr	55	19	while	while	IN
cord-307471-zukjh1hr	55	20	the	the	DT
cord-307471-zukjh1hr	55	21	curves	curve	NNS
cord-307471-zukjh1hr	55	22	differ	differ	VBP
cord-307471-zukjh1hr	55	23	in	in	IN
cord-307471-zukjh1hr	55	24	shape	shape	NN
cord-307471-zukjh1hr	55	25	,	,	,
cord-307471-zukjh1hr	55	26	the	the	DT
cord-307471-zukjh1hr	55	27	same	same	JJ
cord-307471-zukjh1hr	55	28	total	total	JJ
cord-307471-zukjh1hr	55	29	percent	percent	NN
cord-307471-zukjh1hr	55	30	of	of	IN
cord-307471-zukjh1hr	55	31	the	the	DT
cord-307471-zukjh1hr	55	32	population	population	NN
cord-307471-zukjh1hr	55	33	,	,	,
cord-307471-zukjh1hr	55	34	89	89	CD
cord-307471-zukjh1hr	55	35	%	%	NN
cord-307471-zukjh1hr	55	36	is	be	VBZ
cord-307471-zukjh1hr	55	37	infected	infect	VBN
cord-307471-zukjh1hr	55	38	.	.	.
cord-307471-zukjh1hr	56	1	J	J	NNP
cord-307471-zukjh1hr	56	2	o	o	NN
cord-307471-zukjh1hr	56	3	u	u	NN
cord-307471-zukjh1hr	56	4	r	r	NN
cord-307471-zukjh1hr	56	5	n	n	NN
cord-307471-zukjh1hr	56	6	a	a	DT
cord-307471-zukjh1hr	56	7	l	l	NN
cord-307471-zukjh1hr	56	8	P	p	NN
cord-307471-zukjh1hr	56	9	r	r	NN
cord-307471-zukjh1hr	56	10	e	e	NN
cord-307471-zukjh1hr	56	11	-p	-p	NN
cord-307471-zukjh1hr	57	1	r	r	LS
cord-307471-zukjh1hr	58	1	o	o	UH
cord-307471-zukjh1hr	59	1	o	o	UH
cord-307471-zukjh1hr	59	2	f	f	NN
cord-307471-zukjh1hr	59	3	Should	Should	MD
cord-307471-zukjh1hr	59	4	some	some	DT
cord-307471-zukjh1hr	59	5	infected	infected	JJ
cord-307471-zukjh1hr	59	6	people	people	NNS
cord-307471-zukjh1hr	59	7	not	not	RB
cord-307471-zukjh1hr	59	8	live	live	VBP
cord-307471-zukjh1hr	59	9	long	long	RB
cord-307471-zukjh1hr	59	10	enough	enough	RB
cord-307471-zukjh1hr	59	11	to	to	TO
cord-307471-zukjh1hr	59	12	cause	cause	VB
cord-307471-zukjh1hr	59	13	the	the	DT
cord-307471-zukjh1hr	59	14	average	average	JJ
cord-307471-zukjh1hr	59	15	number	number	NN
cord-307471-zukjh1hr	59	16	of	of	IN
cord-307471-zukjh1hr	59	17	secondary	secondary	JJ
cord-307471-zukjh1hr	59	18	infections	infection	NNS
cord-307471-zukjh1hr	59	19	,	,	,
cord-307471-zukjh1hr	59	20	the	the	DT
cord-307471-zukjh1hr	59	21	basic	basic	JJ
cord-307471-zukjh1hr	59	22	reproduction	reproduction	NN
cord-307471-zukjh1hr	59	23	number	number	NN
cord-307471-zukjh1hr	59	24	and	and	CC
cord-307471-zukjh1hr	59	25	generation	generation	NN
cord-307471-zukjh1hr	59	26	time	time	NN
cord-307471-zukjh1hr	59	27	would	would	MD
cord-307471-zukjh1hr	59	28	no	no	RB
cord-307471-zukjh1hr	59	29	longer	longer	RB
cord-307471-zukjh1hr	59	30	be	be	VB
cord-307471-zukjh1hr	59	31	independent	independent	JJ
cord-307471-zukjh1hr	59	32	.	.	.
cord-307471-zukjh1hr	60	1	Be	be	VB
cord-307471-zukjh1hr	60	2	that	that	DT
cord-307471-zukjh1hr	60	3	as	as	IN
cord-307471-zukjh1hr	60	4	it	-PRON-	PRP
cord-307471-zukjh1hr	60	5	may	may	MD
cord-307471-zukjh1hr	60	6	,	,	,
cord-307471-zukjh1hr	60	7	the	the	DT
cord-307471-zukjh1hr	60	8	goal	goal	NN
cord-307471-zukjh1hr	60	9	is	be	VBZ
cord-307471-zukjh1hr	60	10	not	not	RB
cord-307471-zukjh1hr	60	11	just	just	RB
cord-307471-zukjh1hr	60	12	to	to	TO
cord-307471-zukjh1hr	60	13	delay	delay	VB
cord-307471-zukjh1hr	60	14	and	and	CC
cord-307471-zukjh1hr	60	15	reduce	reduce	VB
cord-307471-zukjh1hr	60	16	the	the	DT
cord-307471-zukjh1hr	60	17	peak	peak	NN
cord-307471-zukjh1hr	60	18	number	number	NN
cord-307471-zukjh1hr	60	19	of	of	IN
cord-307471-zukjh1hr	60	20	infections	infection	NNS
cord-307471-zukjh1hr	60	21	,	,	,
cord-307471-zukjh1hr	60	22	possibly	possibly	RB
cord-307471-zukjh1hr	60	23	below	below	IN
cord-307471-zukjh1hr	60	24	surge	surge	NN
cord-307471-zukjh1hr	60	25	capacity	capacity	NN
cord-307471-zukjh1hr	60	26	as	as	IN
cord-307471-zukjh1hr	60	27	some	some	DT
cord-307471-zukjh1hr	60	28	figures	figure	NNS
cord-307471-zukjh1hr	60	29	in	in	IN
cord-307471-zukjh1hr	60	30	the	the	DT
cord-307471-zukjh1hr	60	31	media	medium	NNS
cord-307471-zukjh1hr	60	32	have	have	VBP
cord-307471-zukjh1hr	60	33	suggested	suggest	VBN
cord-307471-zukjh1hr	60	34	,	,	,
cord-307471-zukjh1hr	60	35	it	-PRON-	PRP
cord-307471-zukjh1hr	60	36	is	be	VBZ
cord-307471-zukjh1hr	60	37	also	also	RB
cord-307471-zukjh1hr	60	38	to	to	TO
cord-307471-zukjh1hr	60	39	reduce	reduce	VB
cord-307471-zukjh1hr	60	40	the	the	DT
cord-307471-zukjh1hr	60	41	total	total	JJ
cord-307471-zukjh1hr	60	42	number	number	NN
cord-307471-zukjh1hr	60	43	of	of	IN
cord-307471-zukjh1hr	60	44	infections	infection	NNS
cord-307471-zukjh1hr	60	45	.	.	.
cord-307471-zukjh1hr	61	1	Social	social	JJ
cord-307471-zukjh1hr	61	2	distancing	distancing	NN
cord-307471-zukjh1hr	61	3	accomplishes	accomplish	VBZ
cord-307471-zukjh1hr	61	4	all	all	DT
cord-307471-zukjh1hr	61	5	three	three	CD
cord-307471-zukjh1hr	61	6	objectives	objective	NNS
cord-307471-zukjh1hr	61	7	:	:	:
cord-307471-zukjh1hr	61	8	a	a	LS
cord-307471-zukjh1hr	61	9	)	)	-RRB-
cord-307471-zukjh1hr	61	10	reducing	reduce	VBG
cord-307471-zukjh1hr	61	11	the	the	DT
cord-307471-zukjh1hr	61	12	peak	peak	NN
cord-307471-zukjh1hr	61	13	incidence	incidence	NN
cord-307471-zukjh1hr	61	14	of	of	IN
cord-307471-zukjh1hr	61	15	infections	infection	NNS
cord-307471-zukjh1hr	61	16	,	,	,
cord-307471-zukjh1hr	61	17	b	b	LS
cord-307471-zukjh1hr	61	18	)	)	-RRB-
cord-307471-zukjh1hr	61	19	delaying	delay	VBG
cord-307471-zukjh1hr	61	20	the	the	DT
cord-307471-zukjh1hr	61	21	occurrence	occurrence	NN
cord-307471-zukjh1hr	61	22	of	of	IN
cord-307471-zukjh1hr	61	23	this	this	DT
cord-307471-zukjh1hr	61	24	peak	peak	NN
cord-307471-zukjh1hr	61	25	,	,	,
cord-307471-zukjh1hr	61	26	and	and	CC
cord-307471-zukjh1hr	61	27	c	c	LS
cord-307471-zukjh1hr	61	28	)	)	-RRB-
cord-307471-zukjh1hr	61	29	reducing	reduce	VBG
cord-307471-zukjh1hr	61	30	the	the	DT
cord-307471-zukjh1hr	61	31	total	total	JJ
cord-307471-zukjh1hr	61	32	number	number	NN
cord-307471-zukjh1hr	61	33	of	of	IN
cord-307471-zukjh1hr	61	34	infections	infection	NNS
cord-307471-zukjh1hr	61	35	during	during	IN
cord-307471-zukjh1hr	61	36	epidemics	epidemic	NNS
cord-307471-zukjh1hr	61	37	.	.	.
cord-307471-zukjh1hr	62	1	rate	rate	NN
cord-307471-zukjh1hr	62	2	(	(	-LRB-
cord-307471-zukjh1hr	62	3	contacts	contact	NNS
cord-307471-zukjh1hr	62	4	per	per	IN
cord-307471-zukjh1hr	62	5	person	person	NN
cord-307471-zukjh1hr	62	6	per	per	IN
cord-307471-zukjh1hr	62	7	time	time	NN
cord-307471-zukjh1hr	62	8	period	period	NN
cord-307471-zukjh1hr	62	9	)	)	-RRB-
cord-307471-zukjh1hr	63	1	,	,	,
cord-307471-zukjh1hr	63	2			VB
cord-307471-zukjh1hr	63	3	is	be	VBZ
cord-307471-zukjh1hr	63	4	the	the	DT
cord-307471-zukjh1hr	63	5	probability	probability	NN
cord-307471-zukjh1hr	63	6	of	of	IN
cord-307471-zukjh1hr	63	7	infection	infection	NN
cord-307471-zukjh1hr	63	8	on	on	IN
cord-307471-zukjh1hr	63	9	contact	contact	NN
cord-307471-zukjh1hr	63	10	between	between	IN
cord-307471-zukjh1hr	63	11	a	a	DT
cord-307471-zukjh1hr	63	12	susceptible	susceptible	JJ
cord-307471-zukjh1hr	63	13	and	and	CC
cord-307471-zukjh1hr	63	14	an	an	DT
cord-307471-zukjh1hr	63	15	infectious	infectious	JJ
cord-307471-zukjh1hr	63	16	person	person	NN
cord-307471-zukjh1hr	63	17	,	,	,
cord-307471-zukjh1hr	63	18	and	and	CC
cord-307471-zukjh1hr	63	19	N	n	NN
cord-307471-zukjh1hr	63	20	is	be	VBZ
cord-307471-zukjh1hr	63	21	the	the	DT
cord-307471-zukjh1hr	63	22	total	total	JJ
cord-307471-zukjh1hr	63	23	population	population	NN
cord-307471-zukjh1hr	63	24	size	size	NN
cord-307471-zukjh1hr	63	25	.	.	.
cord-307471-zukjh1hr	63	26	 	 	_SP
cord-307471-zukjh1hr	64	1	The	the	DT
cord-307471-zukjh1hr	64	2	mathematics	mathematic	NNS
cord-307471-zukjh1hr	64	3	of	of	IN
cord-307471-zukjh1hr	64	4	infectious	infectious	JJ
cord-307471-zukjh1hr	64	5	diseases	disease	NNS
cord-307471-zukjh1hr	65	1	The	the	DT
cord-307471-zukjh1hr	65	2	COVID-19	COVID-19	NNP
cord-307471-zukjh1hr	65	3	vaccine	vaccine	NN
cord-307471-zukjh1hr	65	4	development	development	NN
cord-307471-zukjh1hr	65	5	landscape	landscape	NN
cord-307471-zukjh1hr	66	1	Substantial	substantial	JJ
cord-307471-zukjh1hr	66	2	undocumented	undocumented	JJ
cord-307471-zukjh1hr	66	3	infection	infection	NN
cord-307471-zukjh1hr	66	4	facilitates	facilitate	VBZ
cord-307471-zukjh1hr	66	5	the	the	DT
cord-307471-zukjh1hr	66	6	rapid	rapid	JJ
cord-307471-zukjh1hr	66	7	dissemination	dissemination	NN
cord-307471-zukjh1hr	66	8	of	of	IN
cord-307471-zukjh1hr	66	9	novel	novel	JJ
cord-307471-zukjh1hr	66	10	coronavirus	coronavirus	NN
cord-307471-zukjh1hr	66	11	(	(	-LRB-
cord-307471-zukjh1hr	66	12	SARS	SARS	NNP
cord-307471-zukjh1hr	66	13	-	-	HYPH
cord-307471-zukjh1hr	66	14	CoV-2	CoV-2	NNP
cord-307471-zukjh1hr	66	15	)	)	-RRB-
cord-307471-zukjh1hr	67	1	Pathogenesis	Pathogenesis	NNP
cord-307471-zukjh1hr	67	2	of	of	IN
cord-307471-zukjh1hr	67	3	Infectious	Infectious	NNP
cord-307471-zukjh1hr	67	4	Disease	Disease	NNP
cord-307471-zukjh1hr	67	5	Community	Community	NNP
cord-307471-zukjh1hr	67	6	mitigation	mitigation	NN
cord-307471-zukjh1hr	67	7	guidelines	guideline	NNS
cord-307471-zukjh1hr	67	8	to	to	TO
cord-307471-zukjh1hr	67	9	prevent	prevent	VB
cord-307471-zukjh1hr	67	10	pandemic	pandemic	NN
cord-307471-zukjh1hr	67	11	influenza	influenza	NN
cord-307471-zukjh1hr	67	12	-United	-unite	VBD
cord-307471-zukjh1hr	67	13	States	state	NNS
cord-307471-zukjh1hr	68	1	A	a	DT
cord-307471-zukjh1hr	68	2	human	human	JJ
cord-307471-zukjh1hr	68	3	monoclonal	monoclonal	JJ
cord-307471-zukjh1hr	68	4	antibody	antibody	NN
cord-307471-zukjh1hr	68	5	blocking	block	VBG
cord-307471-zukjh1hr	68	6	SARS	SARS	NNP
cord-307471-zukjh1hr	68	7	-	-	HYPH
cord-307471-zukjh1hr	68	8	CoV-2	CoV-2	NNP
cord-307471-zukjh1hr	68	9	infection	infection	NN
cord-307471-zukjh1hr	69	1	In	in	IN
cord-307471-zukjh1hr	69	2	the	the	DT
cord-307471-zukjh1hr	69	3	model	model	NN
cord-307471-zukjh1hr	69	4	that	that	WDT
cord-307471-zukjh1hr	69	5	we	-PRON-	PRP
cord-307471-zukjh1hr	69	6	used	use	VBD
cord-307471-zukjh1hr	69	7	to	to	TO
cord-307471-zukjh1hr	69	8	generate	generate	VB
cord-307471-zukjh1hr	69	9	these	these	DT
cord-307471-zukjh1hr	69	10	figures	figure	NNS
cord-307471-zukjh1hr	69	11	,	,	,
cord-307471-zukjh1hr	69	12	the	the	DT
cord-307471-zukjh1hr	69	13	host	host	NN
cord-307471-zukjh1hr	69	14	population	population	NN
cord-307471-zukjh1hr	69	15	is	be	VBZ
cord-307471-zukjh1hr	69	16	partitioned	partition	VBN
cord-307471-zukjh1hr	69	17	into	into	IN
cord-307471-zukjh1hr	69	18	those	those	DT
cord-307471-zukjh1hr	69	19	who	who	WP
cord-307471-zukjh1hr	69	20	are	be	VBP
cord-307471-zukjh1hr	69	21	susceptible	susceptible	JJ
cord-307471-zukjh1hr	69	22	to	to	IN
cord-307471-zukjh1hr	69	23	infection	infection	NN
cord-307471-zukjh1hr	69	24	,	,	,
cord-307471-zukjh1hr	69	25	S	s	NN
cord-307471-zukjh1hr	69	26	;	;	:
cord-307471-zukjh1hr	69	27	who	who	WP
cord-307471-zukjh1hr	69	28	have	have	VBP
cord-307471-zukjh1hr	69	29	been	be	VBN
cord-307471-zukjh1hr	69	30	infected	infect	VBN
cord-307471-zukjh1hr	69	31	,	,	,
cord-307471-zukjh1hr	69	32	but	but	CC
cord-307471-zukjh1hr	69	33	are	be	VBP
cord-307471-zukjh1hr	69	34	not	not	RB
cord-307471-zukjh1hr	69	35	yet	yet	RB
cord-307471-zukjh1hr	69	36	infectious	infectious	JJ
cord-307471-zukjh1hr	69	37	,	,	,
cord-307471-zukjh1hr	69	38	E	e	NN
cord-307471-zukjh1hr	69	39	;	;	:
cord-307471-zukjh1hr	70	1	who	who	WP
cord-307471-zukjh1hr	70	2	are	be	VBP
cord-307471-zukjh1hr	70	3	infectious	infectious	JJ
cord-307471-zukjh1hr	70	4	,	,	,
cord-307471-zukjh1hr	70	5	I	-PRON-	PRP
cord-307471-zukjh1hr	70	6	;	;	:
cord-307471-zukjh1hr	70	7	who	who	WP
cord-307471-zukjh1hr	70	8	have	have	VBP
cord-307471-zukjh1hr	70	9	recovered	recover	VBN
cord-307471-zukjh1hr	70	10	and	and	CC
cord-307471-zukjh1hr	70	11	are	be	VBP
cord-307471-zukjh1hr	70	12	immune	immune	JJ
cord-307471-zukjh1hr	70	13	,	,	,
cord-307471-zukjh1hr	70	14	R	r	NN
cord-307471-zukjh1hr	70	15	;	;	:
cord-307471-zukjh1hr	70	16	and	and	CC
cord-307471-zukjh1hr	70	17	who	who	WP
cord-307471-zukjh1hr	70	18	have	have	VBP
cord-307471-zukjh1hr	70	19	died	die	VBN
cord-307471-zukjh1hr	70	20	,	,	,
cord-307471-zukjh1hr	70	21	D.In	d.in	ADD
cord-307471-zukjh1hr	70	22	this	this	DT
cord-307471-zukjh1hr	70	23	system	system	NN
cord-307471-zukjh1hr	70	24	of	of	IN
cord-307471-zukjh1hr	70	25	ordinary	ordinary	JJ
cord-307471-zukjh1hr	70	26	differential	differential	JJ
cord-307471-zukjh1hr	70	27	equations	equation	NNS
cord-307471-zukjh1hr	70	28	,	,	,
cord-307471-zukjh1hr	70	29			NNP
cord-307471-zukjh1hr	70	30	is	be	VBZ
cord-307471-zukjh1hr	70	31	the	the	DT
cord-307471-zukjh1hr	70	32	force	force	NN
cord-307471-zukjh1hr	70	33	or	or	CC
cord-307471-zukjh1hr	70	34	hazard	hazard	NN
cord-307471-zukjh1hr	70	35	rate	rate	NN
cord-307471-zukjh1hr	70	36	of	of	IN
cord-307471-zukjh1hr	70	37	infection	infection	NN
cord-307471-zukjh1hr	70	38	,	,	,
cord-307471-zukjh1hr	70	39			CD
cord-307471-zukjh1hr	70	40	is	be	VBZ
cord-307471-zukjh1hr	70	41	the	the	DT
cord-307471-zukjh1hr	70	42	rate	rate	NN
cord-307471-zukjh1hr	70	43	of	of	IN
cord-307471-zukjh1hr	70	44	disease	disease	NN
cord-307471-zukjh1hr	70	45	progression	progression	NN
cord-307471-zukjh1hr	70	46	(	(	-LRB-
cord-307471-zukjh1hr	70	47	its	-PRON-	PRP$
cord-307471-zukjh1hr	70	48	reciprocal	reciprocal	JJ
cord-307471-zukjh1hr	70	49	is	be	VBZ
cord-307471-zukjh1hr	70	50	the	the	DT
cord-307471-zukjh1hr	70	51	latent	latent	JJ
cord-307471-zukjh1hr	70	52	period	period	NN
cord-307471-zukjh1hr	70	53	)	)	-RRB-
cord-307471-zukjh1hr	70	54	,	,	,
cord-307471-zukjh1hr	70	55			NN
cord-307471-zukjh1hr	70	56	is	be	VBZ
cord-307471-zukjh1hr	70	57	the	the	DT
cord-307471-zukjh1hr	70	58	rate	rate	NN
cord-307471-zukjh1hr	70	59	of	of	IN
cord-307471-zukjh1hr	70	60	recovery	recovery	NN
cord-307471-zukjh1hr	70	61	(	(	-LRB-
cord-307471-zukjh1hr	70	62	its	-PRON-	PRP$
cord-307471-zukjh1hr	70	63	reciprocal	reciprocal	NN
cord-307471-zukjh1hr	70	64	is	be	VBZ
cord-307471-zukjh1hr	70	65	the	the	DT
cord-307471-zukjh1hr	70	66	infectious	infectious	JJ
cord-307471-zukjh1hr	70	67	period	period	NN
cord-307471-zukjh1hr	70	68	)	)	-RRB-
cord-307471-zukjh1hr	71	1	,	,	,
cord-307471-zukjh1hr	71	2	p	p	NN
cord-307471-zukjh1hr	71	3	is	be	VBZ
cord-307471-zukjh1hr	71	4	the	the	DT
cord-307471-zukjh1hr	71	5	proportion	proportion	NN
cord-307471-zukjh1hr	71	6	surviving	survive	VBG
cord-307471-zukjh1hr	71	7	(	(	-LRB-
cord-307471-zukjh1hr	71	8	thus	thus	RB
cord-307471-zukjh1hr	71	9	,	,	,
cord-307471-zukjh1hr	71	10	disease	disease	NN
cord-307471-zukjh1hr	71	11	-	-	HYPH
cord-307471-zukjh1hr	71	12	induced	induce	VBN
cord-307471-zukjh1hr	71	13	mortality	mortality	NN
cord-307471-zukjh1hr	71	14	is	be	VBZ
cord-307471-zukjh1hr	71	15	1p	1p	CD
cord-307471-zukjh1hr	71	16	)	)	-RRB-
cord-307471-zukjh1hr	71	17	,	,	,
cord-307471-zukjh1hr	71	18	a	a	DT
cord-307471-zukjh1hr	71	19	is	be	VBZ
cord-307471-zukjh1hr	71	20	the	the	DT
cord-307471-zukjh1hr	71	21	contact	contact	NN
cord-307471-zukjh1hr	71	22	J	J	NNP
cord-307471-zukjh1hr	71	23	o	o	NN
cord-307471-zukjh1hr	71	24	u	u	NN
cord-307471-zukjh1hr	71	25	r	r	NN
cord-307471-zukjh1hr	71	26	n	n	NN
cord-307471-zukjh1hr	71	27	a	a	DT
cord-307471-zukjh1hr	71	28	l	l	NN
cord-307471-zukjh1hr	71	29	P	p	NN
cord-307471-zukjh1hr	71	30	r	r	NN
cord-307471-zukjh1hr	71	31	e	e	NN
cord-307471-zukjh1hr	71	32	-p	-p	NN
cord-307471-zukjh1hr	72	1	r	r	LS
cord-307471-zukjh1hr	73	1	o	o	UH
cord-307471-zukjh1hr	73	2	o	o	NN
cord-307471-zukjh1hr	73	3	f	f	NN